Loading clinical trials...
Loading clinical trials...
Treatment for Migraine and Mood (Team-M): A Pilot Trial of a Mindfulness-based Training Program
The researchers propose a two-arm pilot study of telephone and video delivered Mindfulness-based Cognitive Therapy (MBCT-T and MBCT-V) in people with migraine and depressive symptoms.
This study aims to set the stage for a future definitive large-scale Phase III trial in patients with migraine and depressive symptoms. This first phase is aimed at fidelity optimization of MBCT-T and MBCT-V in people with migraine (defined by the International Classification of Headache Disorders - 3) and depressive symptoms (defined by empirical cut-offs on the Patient Health Questionnaire - 9).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
NYU Langone Health
New York, New York, United States
Start Date
November 11, 2021
Primary Completion Date
June 13, 2022
Completion Date
June 13, 2022
Last Updated
July 18, 2023
27
ACTUAL participants
MBCT-Telephone
BEHAVIORAL
MBCT-Video
BEHAVIORAL
Lead Sponsor
NYU Langone Health
Collaborators
NCT06641466
NCT07018713
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07360600